HHV-6B (Z-29 Strain) Quantitated Viral Load Control

SECTION 2: Hazards identification

OSHA Classification of the substance or mixture

Hazard pictograms

Not Regulated

Signal word

Not Regulated

Hazardous Ingredients

None

Hazard statements

Not Regulated

2.3 Other hazards

This preparation of HHV-6B is a BIOHAZARDOUS material containing ACTIVE VIRUS and should be handled in accordance with biosafety guidelines defined in the BMBL, NIH-CDC HHS Publication No. (CDC) 21-1112. Category: WHO Risk Group 2 Emergency Overview: Biohazardous Pathogenicity: The primary infection of HHV-6 causes Roseola during infancy and early childhood, predominantly by HHV-6B. The symptoms include fever, rash, roseola, rhinorrhea and diarrhea. The reactivation of HHV-6 causing disease has been reported in AIDS patients, one-half of bone marrow transplant recipients and one-third of solid organ transplant recipients. The diagnosis of HHV-6 infection can be established by virus isolation, qualitative and quantitative PCR and IgG and IgM antibody assays by ELISA or IFA. (Original Pathogen Safety Data Sheet and Risk Assessment located at publichealth.gc.ca) Host Range: Humans.

PBT Substances

Not applicable

vPvB Substances

Not applicable

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008 This product is not classified as hazardous according to the Regulation (EC) No 1272/2008 and subsequent amendments. This product is not classified as hazardous according to the Globally Harmonized System (GHS) This product is not classified as hazardous according to OSHA GHS regulations within the U.S.